Use of a sophorolipid to provide free radical formation inhibiting activity or elastase inhibiting activity
US5756471A · kind A · utility
17Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 13, 1996 |
| Grant date | May 26, 1998 |
| Priority date | — |
| Expiry date | Dec 13, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q5/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a cosmetic and/or dermatological composition comprising at least one sophorolipid in its crude or acid form or associated with a monovalent or divalent salt. The concentrations of the sophorolipid can be 0.01% to 30% by weight. In particular, the composition is in the form of a water-in-oil emulsion, and oil-in-water emulsion or an oil-in-water microemulsion. The sophorolipid-based compositions of the invention have a free radical formation inhibiting activity, an elastase inhibiting activity, or an anti-inflammatory activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.